Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-12-15
2010-12-21
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S275000, C544S295000, C544S324000
Reexamination Certificate
active
07855211
ABSTRACT:
The present invention provides a compound of formula (I):or a pharmaceutically acceptable salt thereof which is useful in the treatment of cell proliferative diseases.
REFERENCES:
patent: 2007/0213361 (2007-09-01), Iida et al.
patent: WO 98/11095 (1998-03-01), None
patent: WO 01/60816 (2001-08-01), None
patent: WO 03/062236 (2003-07-01), None
patent: WO 2005/005426 (2005-01-01), None
patent: WO 2005/047279 (2005-05-01), None
patent: WO 2005/070900 (2005-08-01), None
patent: WO 2005/076854 (2005-08-01), None
patent: WO 2006/053109 (2006-05-01), None
patent: WO 2007/089768 (2007-08-01), None
patent: WO 2009/014637 (2009-01-01), None
Bachmann, M. and T. Moroy, Int. J. Biochem. Cell Biol., 37(4):726-30 (2005).
Baughn, L.B. et al., Cancer Res., 66(15):7661 (2006).
Fry, D.W. et al., Mol. Cancer Ther., 3(11):1427-1437 (2004).
Grillo, M. et al., Breast Cancer Research and Treatment, 95:185-194 (2006).
Huang, S. et al., Bioorganic & Medicinal Chemistry Letters, 17:2179-2183 (2007).
Katakami, N., et al., Journal of Biological Chemistry, 279(52):54742-54749 (2004).
Kim, T. M. et al., Cancer Research, 54:605 (1994).
Lee, W.-H. et al., Science, 235:1394 (1987).
Maelandsmo, G.M. et al., British Journal of Cancer, 73:909 (1996).
Marzec, M. et al., Blood, 108(5):1744-1750 (2006).
Pogacic, V. at al., Cancer Res., 67:6916-6924 (2007).
Saab, R. et al., Mol. Cancer Ther., 5(5):1299 (2006).
Schutte, M. et al., Cancer Research, 57:3126 (1997).
Wang, L. et al., Blood, 110(6):2075-2083 (2007).
Coates David A
De Dios Magana Alfonso
De Prado Gonzalez Ana
Del Prado Catalina Miriam Filadelfa
Garcia Paredes Maria Cristina
Eli Lilly and Company
Hostettler Danica
Rao Deepak
LandOfFree
Protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4215223